You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pd-0332991

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Philadelphia (PD-0332991)

Active, not recruiting
Has Results
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • PD-0332991
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Sep 21, 2021

Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

Completed
Has Results
  • Adult Solid Tumor
  • +38 more
  • PD-0332991
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Feb 18, 2021

Tumors, Breast Tumors Trial in Japan (PD-0332991, letrozole)

Completed
Has Results
  • Neoplasms
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +15 more
Oct 28, 2020

Advanced Solid Tumor Malignancies Trial in Washington (PD-0332991, 5-FU, Oxaliplatin)

Unknown status
  • Advanced Solid Tumor Malignancies
  • PD-0332991
  • +2 more
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Mar 2, 2020

Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)

Active, not recruiting
Has Results
  • Breast Neoplasms
  • PD-0332991
  • +2 more
  • Bellflower, California
  • +304 more
Dec 6, 2022

Tumors, Lymphoma, Non-Hodgkin Trial in Detroit, New York, Philadelphia (PD-0332991)

Completed
Has Results
  • Neoplasms
  • Lymphoma, Non-Hodgkin
  • PD-0332991
  • Detroit, Michigan
  • +3 more
Dec 3, 2015

Healthy Trial in South Miami (Midazolam, PD-0332991)

Completed
  • Healthy
  • South Miami, Florida
    Pfizer Investigational Site
Oct 6, 2015

Lymphoma, Mantle-Cell Trial in Boston, New York, Philadelphia (PD-0332991)

Completed
Has Results
  • Lymphoma, Mantle-Cell
  • PD-0332991
  • Boston, Massachusetts
  • +5 more
Oct 6, 2015

Healthy Trial in New Haven (PD-0332991)

Completed
  • Healthy
  • PD-0332991
  • New Haven, Connecticut
    Pfizer Investigational Site
Nov 8, 2012